Access Reimbursement Manager – Mid Central

Posted 3 Days Ago
Be an Early Applicant
Milwaukee, WI
170K-220K Annually
Senior level
Healthtech • Pharmaceutical • Manufacturing
The Role
The Access Reimbursement Manager focuses on minimizing access and reimbursement barriers for patients using Resmetirom by executing a strategic plan in a specific geographic area. The role involves educating healthcare provider (HCP) staff on access expectations, resolving reimbursement issues, and collaborating with internal and external stakeholders. The position also includes monitoring managed care activities and ensuring compliance with policies.
Summary Generated by Built In

About Madrigal: 
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
Opportunity and Summary of Position:

Access Reimbursement Manager

Preferred location: Milwaukee, Madison, North Chicago

The role of the Access Reimbursement Manager (ARM) is to minimize access and reimbursement barriers for patients and providers related to Resmetirom. They will accomplish this by executing the Patient Access strategic plan in a dedicated geographic area with physicians and institutional customers.

The ARM will work closely with internal and external partners including HCP’s, Specialty Pharmacies, Madrigal Patient Support hub and their staff involved in securing appropriate access for Resmetirom. They will work closely with Market Access, Trade and Sales partners in the field, supporting accounts in resolving reimbursement issues and concerns. The ARM is expected to have a deep working knowledge of both public and private payer policies within their market, as it relates to Resmetirom coverage and access.

As with all employees, ARMs are fully accountable for compliance with all laws, regulations, and policies that govern the conduct of Madrigal activities.

Position Responsibilities:

  • Proactively educate prescriber office personnel on access expectations so the HCP may help appropriate patients gain access to Rezdiffra, through virtual and face to face interactions.
  • Reactively address patient/case specific issues and provide issue resolution across the assigned geography.
  • Demonstrate deep knowledge in reimbursement and access across many Patient Support Programs and be the subject matter expert in the geography.
  • Educate and enhance awareness of patient access support offerings, including Hub services, Copay Support etc. 
  • Ensure providers understand payer prior authorization requirements, appeals process, and clinical criteria as it relates to Rezdiffra.
  • Work effectively with both internal and external stakeholders to achieve target objectives and meet established MBO’s/goals.
  • Remain current on key managed care, reimbursement, and policy activities, at the local, regional and national level.
  • Serve as an expert on business trends within key provider accounts.
  • Ensure timely follow-up that demonstrates urgency to both the account and the patient.
  • Ability to monitor SP data; identify issues related to patient access and take quick action to pull necessary stakeholders together to resolve issues expediently.
  • Develop and execute an action plan consisting of prioritized activities to best meet the needs of patients.
  • Work closely with the external and internal customers to trouble shoot any SP related issues.
  • Closely collaborate with the SP account management to solve any customer related issues directly with the SP’s.
  • Responsive to internal sales team’s request for support around appropriate patient issues
  • This will require an estimated 25% overnight travel. This can vary by region and will be confirmed in initial screening.
  • In-person interactions are valued as a way to build strong relationships, conduct in-depth analysis and provide on-site support. This role will require approximately 25% of interactions with healthcare providers to be in-person.

Qualifications and Skills:

  • BA/BS Degree and at least 5 years of pharma, biopharmaceutical, and/or medical device experience calling on field-based customers.
  • Minimum of 2 years of reimbursement or relevant managed care experience.
  • Proven ability to thrive in both an independent setting and within a collaborative cross functional team.
  • Excellent analytical skills focusing on patients and customers, identifying trends and solutions.
  • Strong prioritization skills aligned with good decision-making capabilities.
  • Ability to condense complex reimbursement issues into simple solutions.
  • Ability to lead without authority.
  • Strong oral, written and group communication skills.
  • This will require an estimated 25% overnight travel. This can vary by region and will be confirmed in initial screening.

Compensation:

The expected annual base salary range for this role is between $170,000 – $220,000. Base salary is determined by several factors that include, but are not limited to, a successful candidate's qualifications, skills, education, experience, business needs, and market demands. The role may also be eligible for bonus, equity, and comprehensive benefits, which include flexible paid time off (PTO), medical, dental, vision, and life and disability insurance.

The Company
HQ: Conshohocken, Pennsylvania
430 Employees
On-site Workplace
Year Founded: 2016

What We Do

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com

Similar Jobs

Expert Institute Logo Expert Institute

Research Operations Coordinator

Legal Tech • Professional Services • Software • Business Intelligence • Consulting
Hybrid
Milwaukee, WI, USA
185 Employees

Expert Institute Logo Expert Institute

Research Engagement Coordinator

Legal Tech • Professional Services • Software • Business Intelligence • Consulting
Hybrid
Milwaukee, WI, USA
185 Employees

PwC Logo PwC

Managed Service - Information Technology Outsourcing - Delivery Lead - Senior Manager

Artificial Intelligence • Professional Services • Business Intelligence • Consulting • Cybersecurity • Generative AI
Hybrid
Milwaukee, WI, USA
364000 Employees
104K-233K Annually

PwC Logo PwC

Managed Services - Information Technology Outsourcing - Delivery Lead - Director

Artificial Intelligence • Professional Services • Business Intelligence • Consulting • Cybersecurity • Generative AI
Hybrid
Milwaukee, WI, USA
364000 Employees
143K-317K Annually

Similar Companies Hiring

Accuris Thumbnail
Software • Manufacturing • Machine Learning • Information Technology • Generative AI • Conversational AI
Denver, CO
1200 Employees
Zealthy Thumbnail
Telehealth • Social Impact • Pharmaceutical • Healthtech
New York City, NY
13 Employees
Cencora Thumbnail
Pharmaceutical • Logistics • Healthtech
Conshohocken, PA
46000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account